Solidus Investment

GB SOFT develops non-contact measurement solutions for bio-signals such as pulse, blood pressure, oxygen saturation, and heart rate variability. These signals support basic health checks in daily life and in clinical settings, and analysis can derive fatigue, drowsiness, stress index, and blood sugar. The technology targets automotive, transportation, construction, manufacturing, and well-being industries, with a measurement time under ten seconds and claims high accuracy. The company aims to enable convenient daily life through non-contact bio-signal measurement systems. It also offers a safety management platform that uses camera-based non-contact biosignal detection to support time and attendance, data monitoring, and alerts, including notices of abnormal weather, to enhance safety and business operations.

Dr.Diary is a company that specializes in developing a diabetes management application aimed at assisting users in monitoring and controlling their diabetes. Founded in 2017 and headquartered in Seoul, South Korea, the application allows users to track their blood glucose levels, record daily exercise routines, and receive reminders for medication intake. Additionally, it offers insights into how various foods affect blood sugar levels, thereby helping users make informed dietary choices. The platform includes features such as monthly health reports, daily tips for diabetes management, and communication tools that facilitate personal consultations with healthcare professionals. Through these services, Dr.Diary aims to empower individuals with diabetes to better manage their health and improve their quality of life.

Ubix Therapeutics, Inc. is a research and development company based in Seoul, South Korea, focused on the development of anti-cancer drugs utilizing a proprietary proteolysis targeting chimera platform. The company employs advanced inhibitor technology that degrades specific target proteins within cells, aiming to enhance therapeutic efficacy for various cancers. By binding to proteins associated with disease, Ubix Therapeutics seeks to provide life-saving medications for patients, thereby supporting both patients and medical professionals in the fight against cancer.

Mepsgen is a biotechnology research organization that focuses on pharmaceutical services and drug development.

Novelty Nobility is a biotechnology company specializing in the research and development of antibody-based therapeutics targeting novel angiogenesis factors. The company focuses on ophthalmology and oncology, aiming to address unmet medical needs through innovative treatments.

MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases, and pursues therapeutic diagnostic technologies to enable microbiome-focused treatments. The company’s platform supports safe gastrointestinal microbiota transplant in a medical setting, formulates fecal microbiota transplant capsules for oral administration, and conducts research and development of bacteriophages, with the aim of delivering convenient, economical therapies that reduce infection risk. Through these approaches, MicrobiotiX seeks to advance microbiome and phage therapies for difficult-to-treat conditions, integrating diagnostics with therapeutics to streamline patient care.

DAAN Biotherapeutics is a biopharmaceutical company focused on developing innovative treatments for cancer patients. The company specializes in research and development in the field of cancer therapies, employing a range of approaches such as cell therapies, antibodies, and small molecule inhibitors. DAAN Biotherapeutics is particularly dedicated to immune-oncology, utilizing anticancer immune cell therapies, including natural killer (NK) cells and T cell receptors. Through its independent research infrastructure, the company conducts clinical trials to explore various treatment strategies, aiming to create effective new drugs, particularly for lung cancer. By providing healthcare providers with advanced therapeutic options, DAAN Biotherapeutics seeks to improve outcomes for cancer patients.

Kanaph Therapeutics is a biotechnology company focused on developing next-generation therapeutics for oncology and autoimmune diseases. Founded in 2019 and headquartered in Seoul, South Korea, the company engages in drug development activities ranging from discovery to early-stage clinical trials. Its therapeutic platform includes bi-specific antibodies, Fc-fusions, and small molecules. In oncology, Kanaph Therapeutics develops drugs with enhanced immuno-stimulatory activity in the tumor microenvironment for efficient tumor eradication. For autoimmune diseases, the company's pipeline features bispecific Fc-fusions that inhibit the alternative complement pathway, angiogenesis, and downstream complement activation. The company serves both Korea and the United States.

Founded in 2016, Neurophet is a neuroscience company based in Seoul, South Korea. It specializes in developing advanced brain stimulation simulation software, Neurophet tES Lab, and neuro-navigation technology to aid clinicians in treating patients with brain diseases.

Onnuri Store sells household goods, beauty, health, and food products.

Dot Mill is a mixed reality content production company.

IMBiologics is a biotechnology company focused on developing innovative immunomodulatory antibody drugs aimed at restoring physiological balance. The company specializes in creating novel treatment options for autoimmune diseases and cancer. Its offerings include antibody-based immune modulating biologics that leverage advanced mechanisms of action to modulate the immune system. By utilizing modern biotechnological techniques, IMBiologics enables new approaches to cancer treatment, positioning itself as a key player in the field of immunotherapy.

Optolane Technologies Inc. is a biotechnology company based in Seongnam, South Korea, founded in 2012. The company specializes in manufacturing portable photo sensor chip-based PCR machines for life science applications. It has developed a diagnostic platform that offers molecular and immunoassay point-of-care testing alternatives. Optolane's semiconductor-integrated in-vitro diagnostic devices focus on real-time and digital PCR, utilizing advanced optical and thermal control systems. By providing innovative diagnostic solutions, Optolane aims to facilitate disease diagnosis and enhance the quality of life for individuals.

Healthbiome is a company that researches and develops microbiome-based treatment.

GB SOFT develops non-contact measurement solutions for bio-signals such as pulse, blood pressure, oxygen saturation, and heart rate variability. These signals support basic health checks in daily life and in clinical settings, and analysis can derive fatigue, drowsiness, stress index, and blood sugar. The technology targets automotive, transportation, construction, manufacturing, and well-being industries, with a measurement time under ten seconds and claims high accuracy. The company aims to enable convenient daily life through non-contact bio-signal measurement systems. It also offers a safety management platform that uses camera-based non-contact biosignal detection to support time and attendance, data monitoring, and alerts, including notices of abnormal weather, to enhance safety and business operations.

M2S specializes in creating digital contents of VR and AR.

Jocoos develops engaging platforms for artists and musicians to showcase their talent and connect with industry professionals. Its first product is SURT, a mobile application designed to help users reach their artistic goals by providing opportunities for growth and exposure.

Pharos iBio Co. is a company focused on the development of innovative treatments for rare and intractable diseases. Utilizing a cutting-edge drug development platform that incorporates big data and artificial intelligence, Pharos iBio aims to address significant unmet medical needs. The company’s product pipeline includes several candidate drugs, such as PHI-101-AML for refractory or relapsed acute myeloid leukemia, PHI-101-OC for platinum-resistant or refractory ovarian cancer, and PHI-101-TNBC for metastatic triple-negative breast cancer. Additionally, Pharos iBio is advancing other candidates, including PHI-201, PHI-301, and PHI-501, as part of its commitment to improving patient outcomes in challenging therapeutic areas.

Himedi, Inc. is a digital health platform based in Seoul, South Korea, that facilitates connections between international patients and medical service providers. Founded in 2011, the company offers a hospital reservation service and provides consultations with doctors, ensuring that patients receive personalized recommendations for clinics. Service managers accompany clients throughout their medical journey, enhancing the overall experience for medical tourists. Himedi aims to improve the quality of life for its users by offering comprehensive support during their treatment processes.

Market Designers is a company focused on transforming the brick-and-mortar market by leveraging online innovation to create new business opportunities. The company is developing various housing-related services, including running and cleaning, while also innovating market structures through advanced technology tailored to specific market characteristics. Their on-demand matching platform connects service providers with customers by utilizing algorithms to effectively align consumer needs with available services across sectors such as professional moving, cleaning, mortgage, and education. This approach enhances visibility for service providers and helps them expand their client base.

Orum Therapeutics is a biotechnology company developing therapeutic antibodies using its proprietary cell-penetrating antibody platform. This platform targets specific intracellular proteins for treating genetic diseases and cancer, adapting to different cell types without chemical modifications.

MOTIV Intelligence is an ad-tech company that focuses on automating the marketing process. The company utilizes user behavioral data collected from mobile devices to deliver personalized advertisements to individuals who visit websites but do not complete a purchase. By leveraging this data, MOTIV Intelligence aims to enhance marketing effectiveness and improve conversion rates for businesses.

Orum Therapeutics is a biotechnology company developing therapeutic antibodies using its proprietary cell-penetrating antibody platform. This platform targets specific intracellular proteins for treating genetic diseases and cancer, adapting to different cell types without chemical modifications.

essys is a Manufacturing and sales of automotive IT parts.

Anygen Co., Ltd. is a South Korea-based biotechnology company specializing in peptide APIs and drug development, including GMP-compliant peptide materials and custom, generic, and catalog peptides. The company focuses on peptide biomaterials and new drug development, with programs targeting diseases such as breast cancer, type 2 diabetes, neuropathic pain, and MRSA infections. Founded in 2000 and based in Gwangju, it aims to expand globally through proprietary peptide technologies and quality management processes to supply high-quality peptide drug materials. It is a pioneer in peptide biomaterials in its region and seeks to secure a stable supply of peptide drug raw materials to support public health.

Techcross specializes in manufacturing ballast water management systems. Its products employ electrolysis technologies to prevent pollution from invasive marine species, ensuring compliance with international regulations for large ships.

Purunagun Distribution is a Manufacture and distribution of ice cream with domestic agricultural products.

Cheongwoo Food is a Comprehensive Confectionery.

Vitrosys Inc. is a bio-engineering company based in Yeongju, South Korea, founded in 2002. The company specializes in the development and manufacturing of plant-based medicines, utilizing advanced biotechnological methods to create products from single cells and tissues. Vitrosys offers a diverse range of health-related products, including natural materials, bio reactors, and functional foods designed to promote health. Its product line features cultured roots of Korean mountain ginseng and various extracts, vials, and beverages derived from these roots. Additionally, Vitrosys provides research outsourcing and joint research services, aimed at supporting the industrialization of beneficial plant resources in strictly controlled facilities. The company's commitment to biopharmaceutical innovation enables the extraction and identification of natural metabolites with physiological benefits for human health.

Genomictree, Inc. is a molecular diagnostics company focused on epigenomic biomarker-based technologies. The company develops innovative solutions aimed at addressing unmet needs within the healthcare market. By leveraging advancements in molecular diagnostics, Genomictree strives to enhance disease detection and management, ultimately improving patient outcomes.

Alteogen Inc. is a biotechnology company founded in 2008 and headquartered in Daejeon, South Korea. The company specializes in the development of next-generation biopharmaceuticals, including long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. Alteogen's innovative technologies include NexP Fusion Technology for long-acting biobetters and NexMab ADC Technology for antibody-drug conjugates. Its current pipeline features several candidates in various stages of clinical trials, such as ALT-P1, a long-acting human growth hormone in Phase IIa, and ALT-Q2, a long-acting coagulation factor VII for hemophilia. Additionally, the company is developing ALT-P7 for targeted breast and gastric cancer and ALT-Q5, an antibody-drug conjugate for ovarian cancer. Alteogen also collaborates with other pharmaceutical companies, including Kissei Pharmaceutical and Cristalia, to enhance its product offerings.

Novarex Co., Ltd., founded in 2008 and headquartered in Cheongju, South Korea, specializes in the development and production of health functional foods and raw materials. The company offers a diverse range of dietary supplements, including lactic acid bacteria, probiotics, omega-3 products, and vitamins and minerals. Novarex provides various formulations such as tablets, hard capsules, powders, gummy jellies, and stick jellies, catering to different health needs, including eye health, dietary management, and support for pregnant women and children. Formerly known as Health Science Co., Ltd., Novarex rebranded in November 2011 to reflect its commitment to health and nutrition on both domestic and international markets.

IDAL SYSTEM is a Smart RPC Management System.

Kookdae F & B is a franchise business.

BioLeaders Corporation is a healthcare company based in Yongin, South Korea, founded in 1999. The company focuses on developing innovative medicines, particularly in the field of oncology, with its flagship product being P53, an anti-cancer drug. BioLeaders is advancing several pipeline products, including BLS-H01, currently in phase 3 clinical trials for cervical cancer, and BLS-M07, which has completed phase 2b trials for the same condition. Additionally, the company is working on BLS-M22 for the treatment of Duchenne muscular dystrophy and BLC-H03, a vaccine adjuvant. Beyond pharmaceuticals, BioLeaders also offers health functional foods, raw materials, and functional cosmetic ingredients, positioning itself as a comprehensive provider in the healthcare sector.

Maniker F&G Co., Ltd. is a South Korean company specializing in the production, processing, and sale of frozen, chilled, and retorted food products. Founded in 1993 and headquartered in Yongin, the company offers a diverse range of meat products, including chicken and beef items, aimed at both home and business consumers. Notable offerings include Ginseng chicken stew, Mung bean chicken stew, Premium Samgyetang, boneless chicken tender, and Maniker popcorn chicken. Maniker F&G is also involved in exporting its products to the United States, emphasizing a commitment to providing delicious and safe food options through advanced meat processing technology and continuous innovation.